Yasuto Yoneshima

2.1k citations

54 papers · 944 indexed · h-index 17

Oncology top 5%
- Cancer Immunotherapy and Biomarkers 21
- Lung Cancer Research Studies 9
- Colorectal Cancer Treatments and Studies 5
- Inflammatory Biomarkers in Disease Prognosis 5
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 20
- Lung Cancer Diagnosis and Treatment 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
Geriatrics and Gerontology top 10%
Cancer Research
Immunology
Epidemiology
- Neuroendocrine Tumor Research Advances 4

Co-authors: Kentaro Tanaka Yoichi Nakanishi Isamu Okamoto Eiji Iwama Kohei Otsubo Tetsuzo Tagawa Kazuki Takada Yoshinao Oda
Cited by: Oncology Pulmonary and Respiratory Medicine Geriatrics and Gerontology
Journals: Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)
Partner nations: Japan United States Spain

In The Last Decade

Yasuto Yoneshima

51 papers receiving 940 citations

Peers

Countries citing papers authored by Yasuto Yoneshima

Since Specialization

Citations

This map shows the geographic impact of Yasuto Yoneshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuto Yoneshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuto Yoneshima more than expected).

Fields of papers citing papers by Yasuto Yoneshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuto Yoneshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuto Yoneshima. The network helps show where Yasuto Yoneshima may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yasuto Yoneshima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yasuto Yoneshima Line = papers co-authored together Yasuto Yoneshima links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ORCHARD: Osimertinib Plus Necitumumab in Patients With Epidermal Growth Factor Receptor–Mutated Advanced Non–Small Cell Lung Cancer With a Secondary Epidermal Growth Factor Receptor Alteration Whose Disease Had Progressed on First-Line Osimertinib JCO Precision Oncology ·Jonathan W. Riess,Adrianus J. de Langen,Santiago Ponce,Sarah B. Goldberg,Zofia Piotrowska,Jonathan W. Goldman,Xiuning Le,Byoung Chul Cho,Yasuto Yoneshima,Helen Ambrose,Riccardo Cavazzina,Kwan Ho Tang,James Y. Lau,Helena A. Yu	2025	4
2	TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer npj Precision Oncology ·Ritsu Ibusuki,Eiji Iwama,Atsushi Shimauchi,Hirono Tsutsumi,Yasuto Yoneshima,Kentaro Tanaka,Isamu Okamoto	2024	13
3	Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review Thoracic Cancer ·Yoshihiro Yamamoto,Daisuke Shibahara,Taro Mori,Kohei Otsubo,Yoshimasa Shiraishi,Yasuto Yoneshima,Eiji Iwama,Kentaro Tanaka,Yoshinao Oda,Isamu Okamoto	2024	1
4	Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer Clinical Lung Cancer ·Daisuke Shibahara,Kentaro Tanaka,Osamu Togao,Yoshimasa Shiraishi,Yasuto Yoneshima,Eiji Iwama,Tadamasa Yoshitake,Kousei Ishigami,Isamu Okamoto	2024	3
5	Nintedanib Plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis Annals of the American Thoracic Society ·Satoshi Ikeda,Takashi Ogura,Terufumi Kato,Hirotsugu Kenmotsu,Yoko Agemi,Takaaki Tokito,Kentaro Ito,Kohsuke Isomoto,Yuichi Takiguchi,Yasuto Yoneshima,Toshihide Yokoyama,Toshiyuki Harada,Shigeru Tanzawa,Nobuaki Kobayashi,Tae Iwasawa,Toshihiro Misumi,Hiroaki Okamoto	2024	6
6	Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial Lung Cancer ·Tsuneo Shimokawa,Hiroaki Okamoto,Ryunosuke Machida,Yuki Misumi,Yukio Hosomi,Yasuto Yoneshima,Hiroshi Tanaka,Kyoichi Okishio,Junichi Simizu,Kōichi Goto,Hiroaki Akamatsu,Kaoru Kubota,Kazuhiko Nakagawa,Hidehito Horinouchi,Masahiko Ando,Tomoko Kataoka,Yuichiro Ohe	2023	4
7	Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase Advances in Therapy ·Naoki Inui,Yukihiro Toi,Yasuto Yoneshima,Masahiro Morise,Akito Hata,Kaoru Kubota,Toshiaki Saeki,Tomohide Tamura	2023	5
8	MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma Cancer Science ·Takayuki Nakanishi,Yasuto Yoneshima,Koji Okamura,Toyoshi Yanagihara,Mikiko Hashisako,Takeshi Iwasaki,Naoki Haratake,Shun Mizusaki,Keiichi Ota,Eiji Iwama,Tomoyoshi Takenaka,Kentaro Tanaka,Tomoharu Yoshizumi,Yoshinao Oda,Isamu Okamoto	2023	4
9	Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors Lung Cancer ·Hirono Tsutsumi,Hiroyuki Inoue,Yoshimasa Shiraishi,Aiko Hirayama,Takayuki Nakanishi,Hiroyuki Ando,Maako Nakajima,Seiji Shinozaki,Hiroaki Ogata,Koji Okamura,Shinichi Kimura,Tomohiro Ogawa,Keiichi Ota,Yasuto Yoneshima,Kentaro Tanaka,Naoki Hamada,Isamu Okamoto,Eiji Iwama	2023	8
10	Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer Thoracic Cancer ·Eiji Iwama,Hidetaka Yamamoto,Fumihiko Okubo,Kayo Ijichi,Ritsu Ibusuki,Yoshimasa Shiaraishi,Yasuto Yoneshima,Kentaro Tanaka,Yoshinao Oda,Isamu Okamoto	2023	4
11	YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells Biochemical and Biophysical Research Communications ·Maako Nakajima,Kentaro Tanaka,Yasuto Yoneshima,Sho Yamashita,Daisuke Shibahara,Eiji Iwama,Isamu Okamoto	2023	0
12	Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma Cancer Science ·Koji Okamura,Hiroyuki Inoue,Kentaro Tanaka,Yuki Ikematsu,Rie Furukawa,Keiichi Ota,Yasuto Yoneshima,Eiji Iwama,Isamu Okamoto	2022	5
13	P29-1 LIGHT-NING: An observational study of nivolumab plus ipilimumab with or without chemotherapy for 1st line NSCLC in Japan Annals of Oncology ·Takashi Kijima,Koichi Azuma,Hidetoshi Hayashi,Koichi Nakatani,Tatsuro Fukuhara,Yukihiro Toi,Hisao Imai,Yasuto Yoneshima,Hideaki MIZUTANI,Tomohiro Ozaki,Satoru Kitazono,Naoki Ide,Keisuke Suzuki,Hidehito Horinouchi,Yuichiro Ohe	2022	1
14	Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study Journal of Thoracic Oncology ·Hirotsugu Kenmotsu,Kazushige Wakuda,Keita Mori,Terufumi Kato,Shunichi Sugawara,Keisuke Kirita,Yasuto Yoneshima,Koichi Azuma,Kazumi Nishino,Shunsuke Teraoka,Takehito Shukuya,Ken Masuda,Hidetoshi Hayashi,Ryo Toyozawa,Satoru Miura,Daichi Fujimoto,Kazuhiko Nakagawa,Nobuyuki Yamamoto,Toshiaki Takahashi	2022	90
15	Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer Translational Lung Cancer Research ·Ritsu Ibusuki,Yasuto Yoneshima,Mikiko Hashisako,Norikazu Matsuo,Taishi Harada,Yuko Tsuchiya‐Kawano,Junji Kishimoto,Keiichi Ota,Yoshimasa Shiraishi,Eiji Iwama,Kentaro Tanaka,Yoshinao Oda,Isamu Okamoto	2022	8
16	Neural stem cell–specific ITPA deficiency causes neural depolarization and epilepsy JCI Insight ·Yuichiro Koga,Daisuke Tsuchimoto,Yoshinori Hayashi,Nona Abolhassani,Yasuto Yoneshima,Kunihiko Sakumi,Hiroshi Nakanishi,Shinya Toyokuni,Yusaku Nakabeppu	2020	8
17	NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration Lung Cancer ·Yuki Ikematsu,Kentaro Tanaka,Gouji Toyokawa,Kayo Ijichi,Nobuhisa Ando,Yasuto Yoneshima,Eiji Iwama,Hiroyuki Inoue,Tetsuzo Tagawa,Yoichi Nakanishi,Isamu Okamoto	2020	22
18	Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors Lung Cancer ·Shinkichi Takamori,Kazuki Takada,Mototsugu Shimokawa,Taichi Matsubara,Takatoshi Fujishita,Kensaku Ito,Ryo Toyozawa,Masafumi Yamaguchi,Tatsuro Okamoto,Yasuto Yoneshima,Kentaro Tanaka,Isamu Okamoto,Tetsuzo Tagawa,Masaki Mori	2020	36
19	PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements Lung Cancer ·Yasuto Yoneshima,Kayo Ijichi,Satoshi Anai,Keiichi Ota,Kohei Otsubo,Eiji Iwama,Kentaro Tanaka,Yoshinao Oda,Yoichi Nakanishi,Isamu Okamoto	2018	76
20	Infected complex renal cysts during crizotinib therapy in a patient with non–small cell lung cancer positive for ALK rearrangement Investigational New Drugs ·Yasuto Yoneshima,Isamu Okamoto,Masako Arimura‐Omori,Shinichi Kimura,Noriko Hidaka-Fujimoto,Eiji Iwama,Taishi Harada,Koichi Takayama,Yoichi Nakanishi	2014	9

About Yasuto Yoneshima

Yasuto Yoneshima is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 54 papers that have together received 944 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Oncology (669 citations), Pulmonary and Respiratory Medicine (482 citations) and Geriatrics and Gerontology (27 citations). Yasuto Yoneshima has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Kentaro Tanaka, Yoichi Nakanishi, Isamu Okamoto, Eiji Iwama, Kohei Otsubo, Tetsuzo Tagawa, Kazuki Takada, Yoshinao Oda, Shinkichi Takamori and Mototsugu Shimokawa. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact